First canine XGP case highlights a renal mass diagnostic pitfall
Bottom line
Veterinary clinicians have a new renal mass mimic to keep on their differential list. A newly published case report describes what the authors say is the first confirmed case of xanthogranulomatous pyelonephritis, or XGP, in a dog: a 6-year-old Pomeranian with a markedly enlarged kidney that appeared mass-like on imaging and was treated with radical nephrectomy. Histopathology showed extensive renal parenchymal destruction with lipid-laden macrophage infiltration, confirming XGP rather than neoplasia. In human medicine, XGP is a rare, chronic, destructive inflammatory kidney disease that often presents with obstruction, infection, and imaging findings that can closely resemble renal cancer, especially in focal cases. (casereports.bmj.com)
Why it matters: For veterinary professionals, the case is a reminder that not every unilateral renal mass is malignant. The diagnostic challenge is part of the story: in people, focal XGP is well known to mimic renal tumors on ultrasound and CT, and diagnosis is often made only after nephrectomy and histopathology. That makes this canine report relevant for surgeons, internists, imagers, and pathologists weighing differentials for enlarged, irregular kidneys, particularly when chronic infection or obstruction is also in play. (pmc.ncbi.nlm.nih.gov)
What to watch: Watch for follow-up reports clarifying whether canine XGP has recognizable imaging, microbiologic, or clinicopathologic patterns that could help refine preoperative diagnosis. (pubmed.ncbi.nlm.nih.gov)
Key facts
- Condition
- Xanthogranulomatous pyelonephritis (XGP)
- Species
- Dog
- Patient
- 6-year-old Pomeranian
- Presentation
- Markedly enlarged kidney that appeared mass-like on imaging
- Treatment
- Radical nephrectomy
- Diagnosis
- Confirmed on histopathology
- Pathology
- Extensive renal parenchymal destruction with lipid-laden macrophage infiltration
- Clinical significance
- First confirmed canine case reported
A new case report is putting a rare inflammatory kidney disease on the veterinary radar. The paper describes what the authors identify as the first confirmed canine case of xanthogranulomatous pyelonephritis, or XGP, presenting as a mass-like renal lesion that mimicked neoplasia in a dog. The patient, a 6-year-old Pomeranian, underwent radical nephrectomy after imaging suggested a renal mass, with the final diagnosis made on histopathology. (casereports.bmj.com)
That matters because XGP is already recognized in human medicine as an uncommon but important renal tumor mimic. It is a chronic, destructive form of pyelonephritis characterized by replacement of renal tissue with granulomatous inflammation, abscesses, and sheets of lipid-laden, foamy macrophages. Human reports describe it most often in association with long-standing urinary tract obstruction, renal calculi, and infection, although focal forms can present with fewer classic inflammatory clues and be mistaken for renal cell carcinoma or other malignancies. (pmc.ncbi.nlm.nih.gov)
In the canine case, the key diagnostic pivot came after surgery. According to the report summary, the kidney was markedly enlarged and mass-like on imaging, prompting nephrectomy, but histopathology instead revealed extensive parenchymal destruction and xanthogranulomatous inflammation. That aligns closely with the human literature, where preoperative diagnosis is often difficult and focal disease is especially likely to masquerade as cancer. Several human case reports and reviews note that XGP can appear as a pseudotumor, a complex cyst, or an infiltrative renal mass, and that definitive diagnosis frequently depends on tissue evaluation. (pmc.ncbi.nlm.nih.gov)
There doesn't appear to be much published veterinary commentary yet on this specific canine report, which is not surprising for a single-case clinical pathology finding. Still, the broader medical literature offers useful context. Reviews and case series in people consistently describe XGP as rare, severe, and diagnostically challenging, with imaging overlap that can complicate efforts to distinguish infection, abscessation, and neoplasia before surgery. Some reports also note that while diffuse disease often leads to nephrectomy, selected focal cases in human patients have been worked up with biopsy, drainage, and antimicrobial management when the diagnosis is suspected early enough. (pubmed.ncbi.nlm.nih.gov)
Why it matters: For veterinary professionals, the practical takeaway is less about how often XGP occurs in dogs, which remains unknown, and more about diagnostic framing. A unilateral renal mass in a dog can still justify aggressive treatment when malignancy is high on the list, but this report expands the differential diagnosis to include a severe inflammatory process that may be radiologically indistinguishable from cancer. That has implications for case discussion with pet parents, interpretation of imaging findings, surgical planning, and the value of histopathology in every nephrectomy specimen. It may also prompt more careful review for clues such as chronic infection, obstruction, or atypical inflammatory changes when renal lesions do not fit a clean oncologic picture. (casereports.bmj.com)
The case also underscores the connective tissue between specialties. Radiologists may be the first to flag a suspicious renal lesion, surgeons may be asked to remove what looks like a tumor, and pathologists may ultimately establish that the lesion was inflammatory all along. In human medicine, CT has been described as the imaging modality of choice for XGP, but even there, distinguishing focal XGP from neoplasia can remain difficult. That suggests veterinary teams should be cautious about overinterpreting mass-like renal imaging findings in isolation. (pmc.ncbi.nlm.nih.gov)
What to watch: The next step is whether additional canine cases surface and begin to define a pattern, including breed distribution, culture results, links to nephroliths or urinary obstruction, and whether any preoperative imaging or biopsy features can reliably separate XGP from renal neoplasia. Until then, this report is best viewed as an early signal: rare, but clinically relevant when the differential for a canine renal mass is being built. (pubmed.ncbi.nlm.nih.gov)